Figure 1. The serum levels of CEA, CK18, CK20, CK8, MUC13 and EPCAM in CRC, CA patients and healthy controls. (A) Screening specific genes that encode secretory proteins in CRC by bioinformatics. (B) Testing the expression of candidate serum biomarker genes by Q-PCR in 8 cell lines. (C) Detection of the serum levels of CEA, CK18, CK20, CK8, MUC13 and EPCAM in CRC, CA patients and healthy controls by ELISA.